FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803285616> ?p ?o ?g. }

• W2803285616 endingPage "1354" @default.
• W2803285616 startingPage "1342" @default.
• W2803285616 abstract "To what extent does a trophectoderm (TE) biopsy reliably reflect the chromosomal constitution of the inner cell mass (ICM) in human blastocysts?Concordance between TE and ICM was established in 62.1% of the embryos analysed.Next generation sequencing (NGS) platforms have recently been optimised for preimplantation genetic testing for aneuploidies (PGT-A). However, higher sensitivity has led to an increase in reports of chromosomal mosaicism within a single TE biopsy. This has raised substantial controversy surrounding the prevalence of mosaicism in human blastocysts and the clinical implications of heterogeneity between the TE and ICM.To define the distribution and rate of mosaicism in human blastocysts, we assessed chromosomal profiles of the ICM and multiple TE portions obtained from the same embryo. We evaluated donated embryos with an unknown chromosomal profile (n = 34), as well as PGT-A blastocysts, previously diagnosed as abnormal or mosaic (n = 24). Our intra-embryo comparison included a total of 232 samples, obtained from 58 embryos.Four embryo samples, including the ICM and three distinct TE portions, were acquired from good quality blastocysts by micromanipulation. Whole genome amplification (WGA), followed by NGS was performed on all embryo segments. Profiles were compared between samples from the same embryo, while the results from pretested blastocysts were further correlated to the original report. The embryos investigated in our untested group were obtained from good prognosis patients (n = 25), with maternal age ranging from 23 to 39 years. For the pretested embryo group, maternal age ranged from 23 to 40 years (n = 18).We uncover chromosomal mosaicism, involving both numerical and structural aberrations, in up to 37.9% of the blastocysts analysed. Within the untested group, the overall concordance between the ICM and all TE portions was 55.9%. A normal ICM was detected in 20.6% of blastocysts for which at least one TE portion showed a chromosomal aberration. Conversely, 17.6% of embryos presented with mosaic or uniform abnormalities within the ICM, while showing normal or mosaic TE profiles. For the pretested blastocysts, the overall concordance between the ICM and all TE samples was 70.8%. However, 50% of embryos previously diagnosed with mosaicism did not confirm the original diagnosis. Notably, 31.3% of embryos with a mosaic aberration reported in the original TE biopsy, revealed a euploid profile in the ICM and all three TE samples. Taken together, concordance between the ICM and all TE portions was established in 62.1% of blastocysts, across both embryo groups. Finally, we could not observe a significant effect of age on embryo mosaicism (P = 0.101 untested group; P = 0.7309 pretested group). Similarly, ICM and TE quality were not found to affect the occurrence of chromosomal mosaicism (P = 0.718 and P = 0.462 untested group; P = 1.000 and P = 0.2885 pretested group).All data that support the findings of this study are available online in Vivar (http://cmgg.be/vivar) upon request.Evaluating biological variation in some instances remains challenging. The technological limitations of sampling mitotic errors that lead to mosaicism, as well as WGA artefacts, warrant careful interpretation.Our results highlight the complex nature of genetic (in)stability during early ontogenesis and indicate that blastocysts harbour a higher rate of chromosomal mosaicism than may have been anticipated. Moreover, our findings reveal an overall high diagnostic sensitivity and relatively low specificity in the context of PGT-A. This suggests that a considerable proportion of embryos are potentially being classified as clinically unsuitable. Ultimately, more precise quantification will benefit the clinical management of embryo mosaicism.M.P. is supported by the Special Research Fund, Bijzonder Onderzoeksfonds (BOF01D08114). J.T. and L.D. are supported by the agency for innovation through science (131673, 141441). B.H. and this research are supported by the Special Research Fund, Bijzonder Onderzoeksfonds (BOF15/GOA/011). The authors declare no competing interests.Not applicable." @default.
• W2803285616 created "2018-06-01" @default.
• W2803285616 creator A5000733004 @default.
• W2803285616 creator A5003359086 @default.
• W2803285616 creator A5015831817 @default.
• W2803285616 creator A5029037934 @default.
• W2803285616 creator A5035238346 @default.
• W2803285616 creator A5047878026 @default.
• W2803285616 creator A5055943100 @default.
• W2803285616 creator A5059566655 @default.
• W2803285616 creator A5078452064 @default.
• W2803285616 creator A5082756197 @default.
• W2803285616 creator A5089582737 @default.
• W2803285616 date "2018-05-23" @default.
• W2803285616 modified "2023-10-12" @default.
• W2803285616 title "Chromosomal mosaicism in human blastocysts: the ultimate challenge of preimplantation genetic testing?" @default.
• W2803285616 cites W1972817655 @default.
• W2803285616 cites W1988575240 @default.
• W2803285616 cites W2013884924 @default.
• W2803285616 cites W2102595033 @default.
• W2803285616 cites W2104330394 @default.
• W2803285616 cites W2104658942 @default.
• W2803285616 cites W2108234281 @default.
• W2803285616 cites W2113308856 @default.
• W2803285616 cites W2114396355 @default.
• W2803285616 cites W2116169706 @default.
• W2803285616 cites W2119109764 @default.
• W2803285616 cites W2123599028 @default.
• W2803285616 cites W2124360060 @default.
• W2803285616 cites W2125636389 @default.
• W2803285616 cites W2133381977 @default.
• W2803285616 cites W2144434032 @default.
• W2803285616 cites W2170679460 @default.
• W2803285616 cites W2177179199 @default.
• W2803285616 cites W2270224123 @default.
• W2803285616 cites W2322017433 @default.
• W2803285616 cites W2508908008 @default.
• W2803285616 cites W2510569131 @default.
• W2803285616 cites W2513632557 @default.
• W2803285616 cites W2517681534 @default.
• W2803285616 cites W2523884988 @default.
• W2803285616 cites W2533353936 @default.
• W2803285616 cites W2553234939 @default.
• W2803285616 cites W2561131054 @default.
• W2803285616 cites W2605353647 @default.
• W2803285616 cites W2607487557 @default.
• W2803285616 cites W2609225490 @default.
• W2803285616 cites W2750712999 @default.
• W2803285616 doi "https://doi.org/10.1093/humrep/dey106" @default.
• W2803285616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29796631" @default.
• W2803285616 hasPublicationYear "2018" @default.
• W2803285616 type Work @default.
• W2803285616 sameAs 2803285616 @default.
• W2803285616 citedByCount "80" @default.
• W2803285616 countsByYear W28032856162018 @default.
• W2803285616 countsByYear W28032856162019 @default.
• W2803285616 countsByYear W28032856162020 @default.
• W2803285616 countsByYear W28032856162021 @default.
• W2803285616 countsByYear W28032856162022 @default.
• W2803285616 countsByYear W28032856162023 @default.
• W2803285616 crossrefType "journal-article" @default.
• W2803285616 hasAuthorship W2803285616A5000733004 @default.
• W2803285616 hasAuthorship W2803285616A5003359086 @default.
• W2803285616 hasAuthorship W2803285616A5015831817 @default.
• W2803285616 hasAuthorship W2803285616A5029037934 @default.
• W2803285616 hasAuthorship W2803285616A5035238346 @default.
• W2803285616 hasAuthorship W2803285616A5047878026 @default.
• W2803285616 hasAuthorship W2803285616A5055943100 @default.
• W2803285616 hasAuthorship W2803285616A5059566655 @default.
• W2803285616 hasAuthorship W2803285616A5078452064 @default.
• W2803285616 hasAuthorship W2803285616A5082756197 @default.
• W2803285616 hasAuthorship W2803285616A5089582737 @default.
• W2803285616 hasBestOaLocation W28032856161 @default.
• W2803285616 hasConcept C104317684 @default.
• W2803285616 hasConcept C142724271 @default.
• W2803285616 hasConcept C159399396 @default.
• W2803285616 hasConcept C160798450 @default.
• W2803285616 hasConcept C16685009 @default.
• W2803285616 hasConcept C196843134 @default.
• W2803285616 hasConcept C2775934546 @default.
• W2803285616 hasConcept C2778177303 @default.
• W2803285616 hasConcept C2778805741 @default.
• W2803285616 hasConcept C2779672484 @default.
• W2803285616 hasConcept C2780673598 @default.
• W2803285616 hasConcept C29456083 @default.
• W2803285616 hasConcept C30481170 @default.
• W2803285616 hasConcept C54355233 @default.
• W2803285616 hasConcept C68760520 @default.
• W2803285616 hasConcept C71924100 @default.
• W2803285616 hasConcept C86803240 @default.
• W2803285616 hasConcept C87073359 @default.
• W2803285616 hasConceptScore W2803285616C104317684 @default.
• W2803285616 hasConceptScore W2803285616C142724271 @default.
• W2803285616 hasConceptScore W2803285616C159399396 @default.
• W2803285616 hasConceptScore W2803285616C160798450 @default.
• W2803285616 hasConceptScore W2803285616C16685009 @default.
• W2803285616 hasConceptScore W2803285616C196843134 @default.
• W2803285616 hasConceptScore W2803285616C2775934546 @default.

• next